Another day of slide.
Company needs to clarify:
- Cash runaway given the 6 months BLA review period. 4C out by Wednesday- so cash position coming.
- When is pre-BLA meeting for heart going to happen? Need some more concrete timeline than just "MSB intends to" They have said this year 2024.
- Does the company expect FDA decision on the BLA resub earlier than 6 months at all? They are hopeful but beyond their control- again the 6 month review period does not need time allocated to an ADCOM nor manufacturing inspection- you could reasonably presume a shorter time period. Plus with Phil K saying efficacy was no longer part of the CRL, a lot of trial data would already have been assessed.
Lack of information or news for the next 6 months will only cause SP to keep sliding. Personal opinion is GG will have a price in mind to kick off buying more- he was buying up to $1.15 throughout July prior to the PDUFA date- if it dips to high 90's I will sell the silverware.
Reg
Another day of slide.Company needs to clarify: Cash runaway...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
-0.020(1.78%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.804M | 4.325M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 106231 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 123500 | 16 |
View Market Depth
| Last trade - 14.00pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |